A detailed history of Reyes Financial Architecture, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Reyes Financial Architecture, Inc. holds 150 shares of RVMD stock, worth $6,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Holding current value
$6,057
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025

BUY
$35.36 - $44.42 $5,304 - $6,663
150 New
150 $5.3 Million

Others Institutions Holding RVMD

About Revolution Medicines, Inc.


  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $3.54B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Reyes Financial Architecture, Inc. Portfolio

Follow Reyes Financial Architecture, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reyes Financial Architecture, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Reyes Financial Architecture, Inc. with notifications on news.